American Pacific (APFC) 8-K Index to Consolidated Financial Statements

Exhibit 99.2

Item 1: Financial Statements

Index to Condensed Consolidated Financial Statements

	Page
Condensed Consolidated Balance Sheets	2
Condensed Consolidated Statements of Operations	3
Condensed Consolidated Statements of Cash Flows	4
Notes to Condensed Consolidated Financial Statements	5

- 1 -

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Statements of Operations
(Unaudited, Dollars in Thousands, Except per Share Amounts)

	Three Months Ended
	December 31,
	2006		2005
Revenues	$	34,888	$	16,485
Cost of Revenues		21,980		12,139
Gross Profit		12,908		4,346
Operating Expenses		8,513		5,465
Operating Income (Loss)		4,395		(1,119	)
Interest and Other Income		94		875
Interest Expense		3,303		1,069
Income (Loss) from Continuing Operations before Incomes Tax		1,186		(1,313	)
Income Tax Benefit		547		(523	)
Income (Loss) from Continuing Operations		639		(790	)
Loss from Discontinued Operations, Net of Tax		—		(515	)
Net Income (Loss)	$	639	$	(1,305	)
Basic Earnings (Loss) Per Share:
Income (Loss) from Continuing Operations	$	0.09	$	(0.11	)
Loss from Discontinued Operations, Net of Tax		—		(0.07	)
Net Income (Loss)	$	0.09	$	(0.18	)
Diluted Earnings (Loss) Per Share:
Income (Loss) from Continuing Operations	$	0.09	$	(0.11	)
Loss from Discontinued Operations, Net of Tax		—		(0.07	)
Net Income (Loss)	$	0.09	$	(0.18	)
Weighted Average Shares Outstanding:
Basic		7,324,000		7,297,000
Diluted		7,367,000		7,297,000

See accompanying notes to condensed consolidated financial statements

- 2 -

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited, Dollars in Thousands)

	December 31,			September 30,
	2006			2006
ASSETS
Current Assets:
Cash and Cash Equivalents	$	1,684		$	6,872
Accounts Receivable		17,538			19,474
Notes Receivable		—			7,510
Inventories		53,674			39,755
Prepaid Expenses and Other Assets		2,421			1,845
Deferred Income Taxes		1,887			1,887
Total Current Assets		77,204			77,343
Property, Plant and Equipment, Net		120,027			119,746
Intangible Assets, Net		9,966			14,237
Deferred Income Taxes		21,701			21,701
Other Assets		6,237			6,428
TOTAL ASSETS	$	235,135		$	239,455
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable	$	16,520		$	11,158
Accrued Liabilities		11,875			11,257
Employee Related Liabilities		2,842			4,600
Environmental Remediation Reserves		740			1,631
Deferred Revenues		3,433			5,683
Current Portion of Debt		3,902			9,593
Total Current Liabilities		39,312			43,922
Long-Term Debt		97,497			97,771
Environmental Remediation Reserves		15,758			15,880
Pension Obligations and Other Long-Term Liabilities		9,974			9,998
Total Liabilities		162,541			167,571
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock — No par value; 3,000,000 authorized; none outstanding		—			—
Common Stock — $.10 par value; 20,000,000 shares authorized, 9,359,041 issued		933			933
Capital in Excess of Par Value		86,773			86,724
Retained Earnings		2,951			2,312
Treasury Stock - 2,034,870 shares		(16,982	)		(16,982	)
Accumulated Other Comprehensive Loss		(1,081	)		(1,103	)
Total Shareholders’ Equity		72,594			71,884
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	235,135		$	239,455

See accompanying notes to condensed consolidated financial statements

- 3 -

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Statements of Cash Flow
(Unaudited, Dollars in Thousands)

	Three Months Ended
	December 31,
	2006			2005
Cash Flows from Operating Activities:
Net Income (Loss)	$	639		$	(1,305	)
Adjustments to Reconcile Net Income (Loss) to Net Cash Used by Operating Activities:
Depreciation and amortization		5,144			2,740
Non-cash interest expense		1,075			374
Share-based compensation		49			135
Gain on sale of assets		—			(630	)
Changes in operating assets and liabilities:
Accounts receivable		1,956			(371	)
Inventories		(13,919	)		(6,695	)
Prepaid expenses		(576	)		(2,161	)
Accounts payable and accrued liabilities		4,821			3,461
Deferred revenues		(2,250	)		(256	)
Environmental remediation reserves		(1,013	)		(2,747	)
Pension obligations, net		257			23
Discontinued operations, net		—			805
Other		(164	)		893
Net Cash Used by Operating Activities		(3,981	)		(5,734	)
Cash Flows from Investing Activities:
Acquisition of businesses		—			(111,471	)
Capital expenditures		(1,430	)		(2,443	)
Proceeds from sale of assets		—			2,395
Discontinued operations, net		7,510			(200	)
Net Cash Provided (Used) by Investing Activities		6,080			(111,719	)
Cash Flows from Financing Activities:
Proceeds from the issuance of long-term debt		—			85,000
Payments of long-term debt		(7,287	)		(162	)
Debt issuance costs		—			(1,677	)
Discontinued operations, net		—			(10	)
Net Cash Provided (Used) by Financing Activities		(7,287	)		83,151
Net Change in Cash and cash Equivalents		(5,188	)		(34,302	)
Cash and Cash Equivalents, Beginning of Period		6,872			37,213
Cash and Cash Equivalents, End of Period	$	1,684		$	2,911
Cash Paid For:
Interest	$	2,206		$	39
Income Taxes		68			428
Non-Cash Transactions:
Capital leases originates	$	321		$	—

See accompanying notes to condensed consolidated financial statements

- 4 -

AMERICAN PACIFIC CORPORATION
Notes to Condensed Consolidated Financial Statements
(Unaudited, Dollars in Thousands, Except per Share Amounts)

1.	INTERIM BASIS OF PRESENTATION AND ACCOUNTING POLICIES
	Interim Basis of Presentation:The accompanying condensed consolidated financial statements of American Pacific Corporation and its subsidiaries (the “Company”, “we”, “us”, or “our”) are unaudited, but in our opinion, include all adjustments, which are of a normal recurring nature, necessary for the fair presentation of financial results for interim periods. These statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended September 30, 2006. The operating results and cash flows for the three-month period ended December 31, 2006 are not necessarily indicative of the results that will be achieved for the full fiscal year or for future periods.
	Accounting Policies:A description of our significant accounting policies is included in Note 1 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended September 30, 2006.
	Principles of Consolidation:Our consolidated financial statements include the accounts of American Pacific Corporation and our wholly owned subsidiaries. In connection with our acquisition of the fine chemicals business (the “AFC Business”) of GenCorp, Inc. (“GenCorp”), through the purchase of substantially all of the assets of Aerojet Fine Chemicals LLC and the assumption of certain of its liabilities, we began consolidating our newly formed, wholly-owned subsidiary, Ampac Fine Chemicals (“AFC”) on November 30, 2005 (See Note 2). All significant intercompany accounts have been eliminated.
	Discontinued Operations:In June 2006, our board of directors approved and we committed to a plan to sell our 50% interest in the Energetic Systems (“ESI”) joint venture based on our determination that ESI’s product lines were no longer a strategic fit with our business strategies. We consolidated ESI in accordance with Financial Accounting Standards Board (“FASB”) Interpretation No. 46R (“FIN 46R”), “Consolidation of Variable Interest Entities,” which requires companies to consolidate variable interest entities that either: (1) do not have sufficient equity investment at risk to permit the entity to finance its activities without additional subordinated financial support, or (2) hold a significant variable interest in, or have significant involvement with, an existing variable interest entity. Revenues, expenses and cash flows associated with ESI’s operations are presented as discontinued operations for all periods presented. Effective September 30, 2006, we completed the sale of our interest in ESI. ESI was formerly reported within our Specialty Chemicals operating segment. See Note 12.
	Recently Issued or Adopted Accounting Standards:In July 2006, the FASB issued Interpretation No. 48 (“FIN 48”), “Accounting for Uncertainty in Income Taxes”, which clarifies the accounting for uncertainty in income taxes recognized in the financial statements in accordance with FASB Statement No. 109, “Accounting for Income Taxes”. FIN 48 provides guidance on the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. We are currently evaluating the impact of this standard on our consolidated financial statements.
	In September 2006, the Securities and Exchange Commission (“SEC”) issued Staff Accounting Bulletin No. 108 (“SAB 108”), which documents the SEC staff’s views regarding the process of quantifying financial statement misstatements. Under SAB 108, we must evaluate the materiality of an identified unadjusted error by considering the impact of both the current year error and the cumulative error, if applicable. This also means that both the impact on the current period income

- 5 -

statement and the period-end balance sheet must be considered. SAB 108 is effective for fiscal years ending after November 15, 2006. Any past adjustments required to be recorded as a result of adopting SAB 108 will be recorded as a cumulative effect adjustment to the opening balance of retained earnings. We do not believe the adoption of SAB 108 will have a material impact on our consolidated financial statements.

In September 2006, FASB issued Statement No. 158 (“SFAS 158”) “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R)”, which requires companies to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its balance sheet and to recognize changes in that funded status in the year in which the changes occur through comprehensive income. This statement becomes effective for us on September 30, 2007. We are currently evaluating the impact the adoption of SFAS 158 will have on our consolidated financial statements.

2.	ACQUISITIONS
	AFC Business Acquisition:In July 2005, we entered into an agreement to acquire, and on November 30, 2005, we completed the acquisition of the AFC Business of GenCorp through the purchase of substantially all of the assets of Aerojet Fine Chemicals, LLC and the assumption of certain of its liabilities. The assets were acquired and liabilities assumed by our newly formed, wholly-owned subsidiary, Ampac Fine Chemicals or AFC. AFC is a manufacturer of active pharmaceutical ingredients and registered intermediates under the U.S. Food and Drug Administration’s (“FDA”) current good manufacturing practices (“cGMP”) guidelines for customers in the pharmaceutical industry. Its facilities in California offer specialized engineering capabilities including high containment for high potency compounds, energetic and nucleoside chemistries, and chiral separation using the first commercial-scale simulated moving bed in the United States.
	The total consideration for the AFC Business acquisition is comprised of the following:

Cash	$	88,500
Fair value of Seller Subordinated Note (Face value $25,500)		19,400
Capital expenditures adjustment		17,431
Working capital adjustment		(1,268	)
Earnout adjustment		5,000
Other direct acquisition costs		4,348
Total purchase price	$	133,411

Subordinated Seller Note– The fair value of the Seller Subordinated Note was determined by discounting the required principal and interest payments at a rate of 15%, which the Company believes is appropriate for instruments with comparable terms.

Capital Expenditures Adjustment– The capital expenditures adjustment represents net reimbursements to GenCorp for their cash capital investments, as defined in the acquisition agreements, during the period July 2005 through the closing date on November 30, 2005.

Working Capital Adjustment– The working capital adjustment represents a net adjustment to the purchase price based on actual working capital as of the closing date compared to a target working capital amount specified in the acquisition agreements.

Earnout and EBITDAP Adjustments– The acquisition agreements included a reduction of the purchase price if AFC did not achieve a specified level of earnings before interest, taxes, depreciation, amortization, and pension expense (“EBITDAP”) for the three months ended December 31, 2005, equal to four times the difference between the targeted EBITDAP and the actual EBITDAP achieved, not to exceed $1,000. This target was not met, and accordingly, we received $1,000 from GenCorp. In addition to the amounts paid at closing, the purchase price was subject to an additional contingent cash payment of up to $5,000 based on targeted financial performance of AFC during the year ending September 30, 2006. If the full Earnout Adjustment became payable to GenCorp, the EBITDAP Adjustment also became refundable to GenCorp.

- 6 -

During the year ended September 30, 2006, the AFC financial performance target was exceeded. Accordingly, we recorded a $6,000 payable to GenCorp as of September 30, 2006 and December 31, 2006 (classified as accrued liabilities) comprised of the $5,000 Earnout Payment and the $1,000 refund of the EBITDAP Adjustment. We paid GenCorp $6,000 in February 2007.

Direct Acquisition Costs– Total direct acquisition costs, consisting primarily of legal and due diligence fees, were $4,348.

In connection with the AFC Business acquisition, we entered into Credit Facilities and a Seller Subordinated Note, each discussed in Note 7. The total purchase price was funded with net proceeds from the Credit Facilities of $81,881, the Seller Subordinated Note of $25,500 and existing cash.

This acquisition was accounted for using the purchase method of accounting, under which the total purchase price was allocated to the fair values of the assets acquired and liabilities assumed. We engaged outside consultants to assist in the valuation of property, plant and equipment and intangible assets. As of September 30, 2006, the allocation of the purchase price and the related determination of the useful lives of property, plant and equipment were preliminary and subject to change based on the then pending final valuation report. As a result of the final valuation report, during the first quarter of fiscal 2007, we recorded a reclassification of assigned purchase price from intangible assets to property, plant and equipment, and finalized our estimates of the related remaining useful lives. The final allocation of the purchase price is comprised of the following:

Historical book value of Aerojet Fine Chemicals as of November 30, 2005	$	93,181
Less liabilities not acquired
Payable to GenCorp		24,916
Cash overdraft		3,761
Adjusted historical book value of Aerojet Fine Chemicals as of November 30, 2005		121,858
Estimated fair value adjustments relating to:
Inventories		(84	)
Prepaid expenses		(29	)
Property, plant and equipment		2,633
Customer relationships, average life of 5.5 years		7,957
Backlog, average life of 1.5 years		2,287
Accrued liabilities		651
Pension assets / liabilities		(1,823	)
Other		(39	)
	$	133,411

Intangible assets, consisting of customer relationships and existing customer backlog, have definite lives and will be amortized over their estimated useful lives using the straight-line method.

3.

SHARE-BASED COMPENSATION

On October 1, 2005, we adopted SFAS No. 123R (“SFAS No. 123R”), “Share-Based Payment”, which requires us to measure the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. We have elected to use the Modified Prospective Transition method such that SFAS No. 123R applies to the unvested portion of previously issued awards, new awards and to awards modified, repurchased or canceled after the effective date. Accordingly, commencing October 1, 2005, we recognize share-based compensation for all current award grants and for the unvested portion of previous award grants based on grant date fair values. Prior to fiscal 2006, we accounted for share-based awards under the Accounting Principles Board Opinion No. 25 intrinsic value method, under which no compensation expense was recognized because all historical options granted were at an exercise price equal to the market value of our stock on the grant date. Prior period financial statements have not been adjusted to reflect fair value share-based compensation expense under SFAS No. 123R.

- 7 -

Our share-based payment arrangements are designed to attract and retain employees and directors. The amount, frequency, and terms of share-based awards may vary based on competitive practices, our operating results, and government regulations. New shares are issued upon option exercise or restricted share grants. We do not settle equity instruments in cash. We maintain two share based plans, each as discussed below.

The American Pacific Corporation 2001 Stock Option Plan, as amended (the “2001 Plan”), permits the granting of incentive stock options meeting the requirements of Section 422 of the Internal Revenue Code and nonqualified options that do not meet the requirements of Section 422 to employees, officers, directors and consultants. Options granted under the 2001 Plan generally vest 50% at the grant date and 50% on the one-year anniversary of the grant date, and expire in ten years. As of December 31, 2006, there were 20,000 shares available for grant under the 2001 Plan. This plan was approved by our shareholders.

The American Pacific Corporation 2002 Directors Stock Option Plan (the “2002 Directors Plan”) compensates outside Directors with annual grants of stock options or upon other discretionary events. Options are granted to each eligible director at a price equal to the fair market value of our common stock on the date of the grant. Options granted under the 2002 Directors Plan generally vest 50% at the grant date and 50% on the one-year anniversary of the grant date, and expire in ten years. As of December 30, 2006, there were 25,000 shares available for grant under the 2002 Directors Plan. This plan was approved by our shareholders.

A summary of our outstanding and vested stock option activity for the three months ended December 31, 2006 is as follows:

	Total Outstanding				Non Vested
			Weighted					Weighted
			Average					Average
			Exercise					Fair
			Price					Value
	Shares		Per Share		Shares			Per Share
Balance, September 30, 2006		515,500	$	6.95		18,750		$	1.95
Granted		19,000		7.64		19,000			3.63
Vested		—		—		(28,250	)		2.51
Exercised		—		—		—			—
Expired / Cancelled		—		—		—			—
Balance, December 31, 2006		534,500		6.97		9,500			3.63

A summary of our exercisable stock options as of December 31, 2006 is as follows:

Number of vested stock options		525,000
Weighted-average exercise price per share	$	6.96
Aggregate intrinsic value	$	651
Weighted-average remaining contractual term in years		7.4

- 8 -

We determine the fair value of share-based awards at their grant date, using a Black-Scholes option-pricing model applying the assumptions in the following table. Actual compensation, if any, ultimately realized by optionees may differ significantly from the amount estimated using an option valuation model.

	Three Months Ended
	December 31,
	2006			2005
Weighted-average grant date fair value per share of options granted Significant fair value assuptions:	$	3.68		$	2.00
Expected term in years		5.25			4.75
Expected volatility		47.0	%		50.0	%
Expected dividends		0.0	%		0.0	%
Risk-free interest rates		4.7	%		4.4	%
Total intrinsic value of options exercised	$	—		$	—
Aggregate cash received for option exercises	$	—		$	—
Total compensation cost (included in operating expenses)	$	49		$	134
Tax benefit recognized		18			53
Net compensation cost	$	31		$	81
As of period end date:
Total compensation cost for non-vested awards not yet recognized	$	28		$	290
Weighted-average years to be recognized		0.8			0.7

4.	SELECTED BALANCE SHEET DATA
	Inventories:Inventories consist of the following:

	December 31,			September 30,
	2006			2006
Finished goods	$	5,440		$	7,170
Work-in-process		32,005			20,196
Raw materials and supplies		16,509			12,664
Allowance for obsolete inventory		(280	)		(275	)
Total	$	53,674		$	39,755

Intangible Assets:We account for our intangible assets in accordance with SFAS No. 142, “Goodwill and Other Intangible Assets.” Intangible assets consist of the following:

	December 31,			September 30,
	2006			2006
Perchlorate customer list	$	38,697		$	38,697
Less accumulated amortization		(34,255	)		(33,280	)
		4,442			5,417
Customer relationships and backlog		10,244			13,230
Less accumulated amortization		(5,066	)		(4,756	)
		5,178			8,474
Pension-related intangible		346			346
Total	$	9,966		$	14,237

The perchlorate customer list is an asset of our Specialty Chemicals segment and is subject to amortization. Amortization expense was $975 for both the three months ended December 31, 2006 and 2005.

The pension-related intangible is an actuarially calculated amount related to unrecognized prior service cost for our defined benefit pension plan and supplemental executive retirement plan.

In connection with our acquisition of the AFC Business, we acquired intangible assets with fair values of $7,957 for customer relationships and $2,287 for existing customer backlog. These assets have

- 9 -

definite lives and are assigned to our Fine Chemicals segment. Amortization expense for the three months ended December 31, 2006 and 2005 was $310 and $476, respectively.

5.	COMPREHENSIVE INCOME (LOSS)
	Comprehensive income (loss) consists of the following:

	Three Months Ended
	December 31,
	2006		2005
Net Income (Loss)	$	639	$	(1,305	)
Other Comprehensive Income (Loss) -
Foreign currency translation adjustment		22		(46	)
Comprehensive Income (Loss)	$	661	$	(1,351	)

6.	EARNINGS (LOSS) PER SHARE
	Shares used to compute earnings (loss) per share from continuing operations are as follows:

	Three Months Ended
	December 31,
	2006		2005
Income (Loss) from Continuing Operations	$	639	$	(790	)
Basic:
Weighted average shares		7,324,000		7,297,000
Diluted:
Weighted average shares, basic		7,324,000		7,297,000
Dilutive effect of stock options		43,000		—
Weighted average shares, diluted		7,367,000		7,297,000
Basic loss per share from continuing operations	$	0.09	$	(0.11	)
Diluted loss per share from continuing operations	$	0.09	$	(0.11	)

	As of December 31, 2006 and 2005, we had 226,000 and 561,000 antidilutive options outstanding. The stock options are antidilutive because we are reporting a loss from continuing operations or the exercise price of certain options exceeds the average fair market value of our stock for the period. These options could be dilutive in future periods if our operations are profitable or our stock price increases.
7.	DEBT
	Our outstanding debt balances consist of the following:

	December 31,			September 30,
	2006			2006
Credit Facilities:
First Lien Term Loan, 9.4%, due through 2010	$	57,120		$	64,350
First Lien Revolving Credit		—			—
Second Lien Term Loan plus accrued PIK Interest of $221 and $170, 14.4%, due 2011		20,221			20,170
Subordinated Seller Note plus accrued PIK Interest of $2,965 and $2,226, 10.4%,
Net of Discount of $5,211 and $5,424, due 2012		23,254			22,304
Capital Leases		804			540
Total Debt		101,399			107,364
Less Current Portion		(3,902	)		(9,593	)
Total Long-term Debt	$	97,497		$	97,771

- 10 -

Credit Facilities:In connection with our acquisition of the AFC Business, discussed in Note 2, on November 30, 2005, we entered into a $75,000 first lien credit agreement (the “First Lien Credit Facility”) with Wachovia Bank, National Association and other lenders. We also entered into a $20,000 second lien credit agreement (the “Second Lien Credit Facility,” and together with the First Lien Credit Facility, the “Credit Facilities”) with Wachovia Bank, National Association, and certain other lenders. The Credit Facilities are collateralized by substantially all of our assets and the assets of our domestic subsidiaries. Concurrent with the issuance of our senior notes in February 2007, we amended our First Lien Credit Facility and repaid and terminated our Second Lien Credit Facility.

Seller Subordinated Note:In connection with our acquisition of the AFC Business, discussed in Note 2, we issued an unsecured subordinated seller note in the principal amount of $25,500 to Aerojet-General Corporation, a subsidiary of GenCorp. The note accrued payment-in-kind interest (“PIK Interest”) at a rate equal to the three–month U.S. dollar LIBOR as from time to time in effect plus a margin equal to the weighted average of the interest rate margin for the loans outstanding under the Credit Facilities, including certain changes in interest rates due to subsequent amendments or refinancing of the Credit Facilities. The note was subordinated to the senior debt under or related to the Credit Facilities and certain other indebtedness, subject to certain terms and conditions.

In connection with our February 2007 refinancing activities, we negotiated an early retirement of the Seller Subordinated Note at a discount of approximately $5,000 from the face amount of the note. On February 6, 2007, we paid GenCorp $23,735 representing full settlement of the Seller Subordinated Note and accrued interest.

Senior Notes:On February 6, 2007, we issued and sold $110,000 aggregate principal amount of 9.0% Senior Notes due February 1, 2015 (the “Senior Notes”). The Senior Notes accrue interest at a rate per annum equal to 9.0%, to be payable semi-annually in arrears on each February 1 and August 1, beginning on August 1, 2007. The Senior Notes are guaranteed on a senior unsecured basis by all of our existing and future material U.S. subsidiaries. The Senior Notes are:

• ranked equally in right of payment with all of our existing and future senior indebtedness;

• ranked senior in right of payment to all of our existing and future senior subordinated and subordinated indebtedness;

• effectively junior to our existing and future secured debt to the extent of the value of the assets securing such debt; and

• structurally subordinated to all of the existing and future liabilities (including trade payables) of each of our subsidiaries that do not guarantee the Senior Notes.

The Senior Notes may be redeemed, in whole or in part, under the following circumstances:

• at any time prior to February 1, 2011 at a price equal to 100% of the purchase amount of the Senior Notes plus a “make-whole” premium as defined in the related indenture;

• at any time on or after February 1, 2011 at redemption prices beginning at 104.5% and reducing to 100% by February 1, 2013; and

• until February 1, 2010, up to 35% of the principal amount of the Senior Notes with the proceeds of certain sales of its equity securities.

In addition, if we experience certain changes of control, we must offer to purchase the Notes at 101% of their aggregate principal amount, plus accrued interest.

The Senior Notes were issued pursuant to an Indenture (the “Indenture”) that contains certain covenants limiting, subject to exceptions, carve-outs and qualifications, our ability to:

• incur additional debt;

• pay dividends or make other restricted payments;

• create liens on assets to secure debt;

• incur dividend or other payment restrictions with regard to restricted subsidiaries;

- 11 -

• transfer or sell assets;

• enter into transactions with affiliates;

• enter into sale and lease back transactions;

• create an unrestricted subsidiary;

• enter into certain business activities; or

• effect a consolidation, merger or sale of all or substantially all of our assets.

The Indenture also contains certain customary events of default.

In connection with the closing of the sale of the Senior Notes, we entered into a registration rights agreement and agreed to use our reasonable best efforts to:

• file a registration statement with respect to an offer to exchange the Senior Notes for notes that have substantially identical terms as the Senior Notes and are registered under the Securities Act of 1933, as amended (the “Securities Act”);

• cause the registration statement to become effective within 210 days after the closing; and

• consummate the exchange offer within 240 days after the closing.

If we cannot effect an exchange offer within the time periods listed above, we have agreed to file a shelf registration statement for the resale of the Senior Notes. If we do not comply with certain of our obligations under the registration rights agreement (a “Registration Default”), the annual interest rate on the Senior Notes will increase by 0.25%. The annual interest rate on the Senior Notes will increase by an additional 0.25% for any subsequent 90 day period during which the Registration Default continues, up to a maximum additional interest rate of 1.00% per year. If we correct the Registration Default, the interest rate on the Senior Notes will revert immediately to the original rate.

Revolving Credit Facility: On February 6, 2007, we entered into an Amended and Restated Credit Agreement which provides a secured revolving credit facility in an aggregate principal amount of up to $20.0 million (the “Revolving Credit Facility”) with an initial maturity in 5 years. We may prepay and terminate the Revolving Credit Facility at any time. The annual interest rates applicable to loans under the Revolving Credit Facility will be at our option, the Alternate Base Rate or LIBOR Rate (each as defined in the Revolving Credit Facility) plus, in each case, an applicable margin. The applicable margin will be tied to our total leverage ratio (as defined in the Revolving Credit Facility). In addition, we will pay commitment fees, other fees related to the issuance and maintenance of the letters of credit, and certain agency fees.

The Revolving Credit Facility is guaranteed by and secured by substantially all of the assets of our current and future domestic subsidiaries, subject to certain exceptions as set forth in the Revolving Credit Facility. The Revolving Credit Facility contains certain negative covenants restricting and limiting our ability to, among other things:

• incur debt, incur contingent obligations and issue certain types of preferred stock;

• create liens;

• pay dividends, distributions or make other specified restricted payments;

• make certain investments and acquisitions;

• enter into certain transactions with affiliates;

• enter into sale and leaseback transactions; and

• merge or consolidate with any other entity or sell, assign, transfer, lease, convey or otherwise dispose of assets.

Financial covenants under the Revolving Credit Facility include quarterly requirements for total leverage ratio of less than or equal to 5.25 to 1.00, and interest coverage ratio of at least 2.50 to 1.00. The Revolving Credit Facility also contains usual and customary events of default (subject to certain threshold amounts and grace periods). If an event of default occurs and is continuing, we may be required to repay the obligations under the Revolving Credit Facility prior to its stated maturity and the

- 12 -

related commitments may be terminated. We were in compliance with the financial covenants of our Revolving Credit Facility as of the inception date, February 6, 2007.

Letters of Credit:As of December 31, 2006, we had $2,332 in outstanding standby letters of credit which mature through May 2012. These letters of credit principally secure performance of certain environmental protection equipment sold by us and payment of fees associated with the delivery of natural gas and power.

Interest Rate Swap Agreements: In May 2006, we entered into two interest rate swap agreements, expiring on June 30, 2008, for the purpose of hedging a portion of our exposure to changes in variable rate interest on our Credit Facilities. Under the terms of the swap agreements, which have an aggregate notional amount of $41,769 at December 31, 2006, we pay fixed rate interest and receive variable rate interest based on a specific spread over three-month LIBOR. The differential to be paid or received is recorded as an adjustment to interest expense. The swap agreements do not qualify for hedge accounting treatment. We record an asset or liability for the fair value of the swap agreements, with the effect of marking these contracts to fair value being recorded as an adjustment to interest expense. The aggregate fair values of the swap agreements at December 31, 2006 and September 30, 2006, which are recorded as other long-term liabilities, were $215 and $314, respectively.

8.	COMMITMENTS AND CONTINGENCIES
	Environmental Matters:
	Review of Perchlorate Toxicity by the EPA –
	Perchlorate (the “anion”) is not currently included in the list of hazardous substances compiled by the U.S. Environmental Protection Agency (“EPA”), but it is on the EPA’s Contaminant Candidate List. The EPA has conducted a risk assessment relating to perchlorate, two drafts of which were subject to formal peer reviews held in 1999 and 2002. Following the 2002 peer review, the EPA perchlorate risk assessment together with other perchlorate related science was reviewed by the National Academy of Sciences (“NAS”). This NAS report was released on January 11, 2005. The recommendations contained in this NAS report indicate that human health is protected in drinking water at a level of 24.5 parts per billion (“ppb”). Certain states have also conducted risk assessments and have set preliminary levels from 1 – 14 ppb. The EPA has established a reference dose for perchlorate of .0007 mg/kg/day which is equal to a Drinking Water Equivalent Level (“DWEL”) of 24.5 ppb. A decision as to whether or not to establish a Maximum Contaminate Level (“MCL”) is pending. The outcome of these federal EPA actions, as well as any similar state regulatory action, will influence the number, if any, of potential sites that may be subject to remediation action.
	Perchlorate Remediation Project in Henderson, Nevada –
	We commercially manufactured perchlorate chemicals at a facility in Henderson, Nevada (the “Ampac Henderson Site”) from 1958 until the facility was destroyed in May 1988, after which we relocated our production to a new facility in Iron County, Utah. Kerr-McGee Chemical Corp (“KMCC”) also operated a perchlorate production facility in Henderson, Nevada from 1967 to 1998. Between 1956 to 1967, American Potash operated a perchlorate production facility at the same site. For many years prior to 1956, other entities also manufactured perchlorate chemicals at that site. In 1998, Kerr-McGee Chemical LLC became the operating entity and it ceased the production of perchlorate at the Kerr McGee Henderson Site. Thereafter, it continued to produce other chemicals at this site until it was recently sold. As a result of a longer production history at Henderson, KMCC and its predecessor operations have manufactured significantly greater amounts of perchlorate over time than we did at the Ampac Henderson Site.
	In 1997, the Southern Nevada Water Authority (“SNWA”) detected trace amounts of the perchlorate anion in Lake Mead and the Las Vegas Wash. Lake Mead is a source of drinking water for Southern

- 13 -

Nevada and areas of Southern California. The Las Vegas Wash flows into Lake Mead from the Las Vegas valley.

In response to this discovery by SNWA, and at the request of the Nevada Division of Environmental Protection (“NDEP”), we engaged in an investigation of groundwater near the Ampac Henderson site and down gradient toward the Las Vegas Wash. That investigation and related characterization which lasted more than six years employed experts in the field of hydrogeology. This investigation concluded that, although there is perchlorate in the groundwater in the vicinity of the Ampac Henderson Site up to 700 ppm, perchlorate from this Site does not materially impact, if at all, water flowing in the Las Vegas Wash toward Lake Mead. It has been well established, however, by data generated by SNWA and NDEP, that perchlorate from the Kerr McGee Henderson Site did materially impact the Las Vegas Wash and Lake Mead. Kerr McGee’s successor, Tronox LLC, operates an ex situ perchlorate groundwater remediation facility at their Henderson site and this facility has had a significant effect on the load of perchlorate entering Lake Mead over the last 5 years. Recent measurements of perchlorate in Lake Mead made by SNWA have been less than 10 ppb.

Notwithstanding these facts, and at the direction of NDEP and the EPA, we conducted an investigation of remediation technologies for perchlorate in groundwater with the intention of remediating groundwater near the Ampac Henderson Site. The technology that was chosen as most efficient and appropriate is in situ bioremediation (“ISB”). The technology reduces perchlorate in the groundwater by precise addition of an appropriate carbon source to the groundwater itself while it is still in the ground (as opposed to an above ground, more conventional, ex situ process). This induces naturally occurring organisms in the groundwater to reduce the perchlorate among other oxygen containing compounds.

In 2002, we conducted a pilot test in the field of the ISB technology and it was successful. On the basis of the successful test and other evaluations, in fiscal 2005 we submitted a work plan to NDEP for the construction of a remediation facility near the Ampac Henderson Site. The conditional approval of the work plan by NDEP in our third quarter of fiscal 2005 allowed us to generate estimated costs for the installation and operation of the remediation facility that will address perchlorate from the Ampac Henderson Site. We commenced construction July 2005. In December 2006, we began operations, reducing perchlorate concentrations in system extracted groundwater in Henderson.

Henderson Site Environmental Remediation Reserve –

During our fiscal 2005 third quarter, we recorded a charge for $22,400 representing our estimate of the probable costs of our remediation efforts at the Henderson Site, including the costs for equipment, operating and maintenance costs, and consultants. Key factors in determining the total estimated cost include an estimate of the speed of groundwater entering the treatment area, which was then used to estimate a project life of 45 years, as well as estimates for capital expenditures and annual operating and maintenance costs. The project consists of two primary phases; the initial construction of the remediation equipment and the operating and maintenance phase. During our fiscal 2006, we increased our total cost estimate for the construction phase by $3,600 due primarily to changes in the engineering designs, delays in receiving permits and the resulting extension of construction time. We commenced the construction phase in late fiscal 2005, completed an interim system in June 2006, and completed the permanent facility in December 2006. These estimates are based on information currently available to us and may be subject to material adjustment upward or downward in future periods as new facts or circumstances may indicate.

- 14 -

A summary of our environmental reserve activity for the three months ended December 31, 2006 is shown below:

Balance, September 30, 2006	$	17,511
Additions or adjustments		—
Expenditures		(1,013	)
Balance, December 31, 2006	$	16,498

AFC Environmental Matters –

AFC’s facility is located on land leased from Aerojet. The leased land is part of a tract of land owned by Aerojet designated as a “Superfund Site” under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA). The tract of land had been used by Aerojet and affiliated companies to manufacture and test rockets and related equipment since the 1950s. Although the chemicals identified as contaminants on the leased land were not used by Aerojet Fine Chemicals as part of its operations, CERCLA, among other things, provides for joint and severable liability for environmental liabilities including, for example, the environmental remediation expenses.

As part of the agreement to sell the AFC Business, an Environmental Indemnity Agreement was entered into whereby GenCorp agreed to indemnify us against any and all environmental costs and liabilities arising out of or resulting from any violation of environmental law prior to the effective date of the sale, or any release of hazardous substances by the AFC Business, Aerojet or GenCorp on the AFC premises or Aerojet’s Sacramento site prior to the effective date of the sale.

On November 29, 2005, EPA Region IX provided us with a letter indicating that the EPA does not intend to pursue any clean up or enforcement actions under CERCLA against future lessees of the Aerojet Fine Chemicals property for existing contamination, provided that the lessees do not contribute to or do not exacerbate existing contamination on or under the Aerojet Superfund site.

Employment Matters: Effective March 25, 2006, the employment of Dr. Seth Van Voorhees, as our Chief Financial Officer, Vice President and Treasurer, terminated. Dr. Van Voorhees was employed by us pursuant to an employment agreement dated December 1, 2005. On December 6, 2006, we reached a settlement with Dr. Van Voorhees under which we paid Dr. Van Voorhees $600 and both parties entered into a standard mutual release.

Other Matters:We are from time to time involved in other claims or lawsuits. We believe that current claims or lawsuits against us, individually and in the aggregate, will not have a material adverse effect on our financial condition, cash flows or results of operations.

9.	SEGMENT INFORMATION
	We report our business in four operating segments: Specialty Chemicals, Fine Chemicals, Aerospace Equipment and Other Businesses. These segments are based upon business units that offer distinct products and services, are operationally managed separately and produce products using different production methods. Segment operating profit includes all sales and expenses directly associated with each segment. Environmental remediation charges, corporate general and administrative costs, which consist primarily of executive, investor relations, accounting, human resources and information technology expenses, and interest are not allocated to segment operating results.
	Specialty Chemicals:Our Specialty Chemicals segment manufactures and sells: (i) perchlorate chemicals, used principally in solid rocket propellants for the space shuttle and defense programs, (ii) sodium azide, a chemical used in pharmaceutical manufacturing and historically used principally in

- 15 -

the inflation of certain automotive airbag systems, and (iii) Halotronâ, clean gas fire extinguishing agents designed to replace halons.

One perchlorates customer accounted for 16% of our consolidated revenues for the three months ended December 31, 2006. No single perchlorate customer exceeded 10% of our consolidated revenues for the three months ended December 31, 2005.

Fine Chemicals:On November 30, 2005, we created a new operating segment, Fine Chemicals, to report the financial performance of AFC (See Note 2). AFC is a manufacturer of active pharmaceutical ingredients and registered intermediates under cGMP guidelines for commercial customers in the pharmaceutical industry, involving high potency compounds, energetic and nucleoside chemistries, and chiral separation.

For the three months ended December 31, 2006, three Fine Chemicals customers accounted for 20%, 14%, and 10% of our consolidated revenues. For the three months ended December 31, 2005, one Fine Chemicals customer accounted for 20% of our consolidated revenues.

Aerospace Equipment:The Aerospace Equipment, or ISP business, manufactures and sells in-space propulsion systems, thrusters (monopropellant or bipropellant) and propellant tanks.

Other Businesses:Our Other Businesses segment contains our water treatment equipment and real estate activities. Our water treatment equipment business designs, manufactures and markets systems for the control of noxious odors, the disinfection of water streams and the treatment of seawater.

The following provides financial information about our segment operations:

	Three Months Ended
	December 31,
	2006			2005
Revenues:
Specialty Chemicals	$	11,790		$	4,705
Fine Chemicals		17,591			5,172
Aerospace Equipment		3,976			4,645
Other Businesses		1,531			1,963
Total Revenues	$	34,888		$	16,485
Segment Operating Income (Loss):
Specialty Chemicals	$	3,493		$	420
Fine Chemicals		2,919			951
Aerospace Equipment		186			261
Other Businesses		593			517
Total Segment Operating Income		7,191			2,149
Corporate Expenses		(2,796	)		(3,268	)
Interest and Other Income (Expense), Net		(3,209	)		(194	)
Loss from Continuing Operations before Tax	$	1,186		$	(1,313	)
Depreciation and Amortization:
Specialty Chemicals	$	1,282		$	1,279
Fine Chemicals		3,697			1,300
Aerospace Equipment		32			17
Other Businesses		3			3
Corporate		130			141
Total Depreciation and Amortization	$	5,144		$	2,740

- 16 -

10.	INTEREST AND OTHER INCOME
	Interest and other income consist of the following:

	Three Months Ended
	December 31,
	2006		2005
Interest income	$	94	$	246
Gain on sale of Hughes Parkway		—		580
Other		—		49
	$	94	$	875

	We owned a 70% interest as general and limited partner in Gibson Business Park Associates 1986-1 (the “Partnership”), a real estate development limited partnership. The remaining 30% limited partners included certain current and former members of our board of directors. The Partnership, in turn, owned a 33% limited partnership interest in 3770 Hughes Parkway Associates Limited Partnership, a Nevada limited partnership (“Hughes Parkway”). Hughes Parkway owns the building in which we lease office space in Las Vegas, Nevada.
	In October 2005, the Partnership sold its interest in Hughes Parkway, which resulted in a net gain and cash distribution to us of $2,395. Concurrent with, and as a condition of, the sale of the Partnership’s interest in Hughes Parkway, we renewed our office space lease through February 2009. We accounted for the transaction as a sale leaseback. Accordingly, we deferred gain totaling $1,815 representing the present value of future lease payments. We amortize the deferred gain (as a reduction of rental expense), using the straight-line method over the term of the lease. We recognized the remaining gain of $580, which is reported as interest and other income.
11.	DEFINED BENEFIT PLANS
	We maintain three defined benefit pension plans which cover substantially all of our U.S. employees, excluding employees of our Aerospace Equipment Segment: the American Pacific Corporation Defined Benefit Pension Plan (“Ampac Plan”), the Ampac Fine Chemical LLC Pension Plan for Salaried Employees (“AFC Salaried Plan”), and the Ampac Fine Chemical LLC Pension Plan for Bargaining Unit Employees (“AFC Bargaining Plan”). Collectively, these three plans are referred to as the “Pension Plans”. The AFC Salaried Plan and the AFC Bargaining Plan were established in connection with our acquisition of the AFC business and include the assumed liabilities for pension benefits to existing employees at the acquisition date. In addition, we have a supplemental executive retirement plan (“SERP”) that includes our former and current Chief Executive Officer.
	Net periodic pension cost related to the Pension Plans consists of the following:

	Three Months Ended
	December 31,
	2006			2005
Pension Plans:
Service Cost	$	391		$	227
Interest Cost		425			349
Expected Return on Plan Assets		(376	)		(288	)
Recognized Actuarial Losses		123			12
Amortization of Prior Service Costs		12			98
Net Periodic Pension Cost	$	575		$	398
SERP:
Service Cost	$	—		$	—
Interest Cost		35			37
Expected Return on Plan Assets		—			—
Recognized Actuarial Losses		6			11
Amortization of Prior Service Costs		11			7
Net Periodic Pension Cost	$	52		$	55

- 17 -

	For the three months ended December 31, 2006, we contributed $479 to the Pension Plan to fund benefit payments and anticipate making approximately $2,226 in additional contributions through September 30, 2007. For the three months ended December 31, 2006, we contributed $32 to the SERP to fund benefit payments and anticipate making approximately $95 in additional contributions through September 30, 2007.
12.	DISCONTINUED OPERATIONS
	In June 2006, our board of directors approved and we committed to a plan to sell our interest in ESI, based on our determination that ESI’s product lines were no longer a strategic fit with our business strategies. Revenues and expenses associated with ESI’s operations are presented as discontinued operations for all periods presented. ESI was formerly reported within our Specialty Chemicals segment.
	Effective September 30, 2006, we completed the sale of our interest in ESI for $7,510, which, after deducting direct expenses, resulted in a gain on the sale before income taxes of $258. The ESI sale proceeds are reflected as a note receivable as of September 30, 2006 and we collected the amount in full in October 2006.
	Summarized financial information for ESI is as follows for the three months ended December 31, 2005:

Revenues	$	2,632
Discontinued Operations:
Operating loss before tax		(844	)
Benefit for income tax		(329	)
Net loss from discontinued operations	$	(515	)

13.

GUARANTOR SUBSIDIARIES

As discussed in Note 7, on February 6, 2007, American Pacific Corporation, a Delaware Corporation (“Parent”) issued and sold $110,000 aggregate principal amount of Senior Notes. In connection with the issuance of the Senior Notes, the Company’s U.S. subsidiaries (“Guarantor Subsidiaries”) jointly, fully, severally, and unconditionally guaranteed the Senior Notes. The Company’s sole foreign subsidiary (“Non-Guarantor Subsidiary”) is not a guarantor of the Senior Notes. The Parent has no independent assets or operations. The following presents condensed consolidating financial information separately for the Parent, Guarantor Subsidiaries and Non-Guarantor Subsidiary:

- 18 -

Condensed Consolidating Balance Sheet -			Guarantor			Non-Guarantor
December 31, 2006	Parent		Subsidiaries			Subsidiary			Eliminations			Consolidated
Assets:
Cash and Cash Equivalents	$	—	$	1,590		$	94		$	—		$	1,684
Accounts Receivable		—		17,628			1,123			(1,213	)		17,538
Inventories		—		52,878			796			—			53,674
Prepaid Expenses and Other Assets		—		2,355			66			—			2,421
Deferred Income Taxes		—		1,887			—			—			1,887
Total Current Assets		—		76,338			2,079			(1,213	)		77,204
Property, Plant and Equipment, Net		—		119,905			122			—			120,027
Intangible Assets, Net		—		9,966			—			—			9,966
Deferred Income Taxes		—		21,701			—			—			21,701
Other Assets		—		6,237			—			—			6,237
Intercompany Advances		74,159		1,551			—			(75,710	)		—
Investment in Subsidiaries		99,030		(5	)		—			(99,025	)		—
Total Assets	$	173,189	$	235,693		$	2,201		$	(175,948	)	$	235,135
Liabilities and Stockholders’ Equity:
Accounts Payable and Other Current Liabilities	$	—	$	31,795		$	655		$	(1,213	)	$	31,237
Environmental Remediation Reserves		—		740			—			—			740
Deferred Revenues		—		3,433			—			—			3,433
Intercompany Advances		—		74,159			1,551			(75,710	)		—
Current Portion of Debt		3,652		250			—			—			3,902
Total Current Liabilities		3,652		110,377			2,206			(76,923	)		39,312
Long-Term Debt		96,943		554			—			—			97,497
Environmental Remediation Reserves		—		15,758			—			—			15,758
Other Long-Term Liabilities		—		9,974			—			—			9,974
Total Liabilities		100,595		136,663			2,206			(76,923	)		162,541
Total Stockholders’ Equity		72,594		99,030			(5	)		(99,025	)		72,594
Total Liabilities and Stockholders’ Equity	$	173,189	$	235,693		$	2,201		$	(175,948	)	$	235,135

- 19 -

Condensed Consolidating Balance Sheet -				Guarantor			Non-Guarantor
September 30, 2006	Parent			Subsidiaries			Subsidiary			Eliminations			Consolidated
Assets:
Cash and Cash Equivalents	$	—		$	6,758		$	114		$	—		$	6,872
Accounts Receivable		—			19,253			1,040			(819	)		19,474
Notes Receivable		—			7,510			—			—			7,510
Inventories		—			39,152			603			—			39,755
Prepaid Expenses and Other Assets		—			1,745			100			—			1,845
Deferred Income Taxes		—			1,887			—			—			1,887
Total Current Assets		—			76,305			1,857			(819	)		77,343
Property, Plant and Equipment, Net		—			119,623			123			—			119,746
Intangible Assets, Net		—			14,237			—			—			14,237
Deferred Income Taxes		—			21,701			—			—			21,701
Other Assets		—			6,428			—			—			6,428
Intercompany Advances		81,389			975			—			(82,364	)		—
Investment in Subsidiaries		97,320			56			—			(97,376	)		—
Total Assets	$	178,709		$	239,325		$	1,980		$	(180,559	)	$	239,455
Liabilitites and Stockholders’ Equity:
Accounts Payable and Other Current Liabilities	$	—		$	26,885		$	949		$	(819	)	$	27,015
Environmental Remediation Reserves		—			1,631			—			—			1,631
Deferred Revenues		—			5,683			—			—			5,683
Intercompany Advances	��	—			81,389			975			(82,364	)		—
Current Portion of Debt		9,422			171			—			—			9,593
Total Current Liabilities		9,422			115,759			1,924			(83,183	)		43,922
Long-Term Debt		97,403			368			—			—			97,771
Environmental Remediation Reserves		—			15,880			—			—			15,880
Other Long-Term Liabilities		—			9,998			—			—			9,998
Total Liabilities		106,825			142,005			1,924			(83,183	)		167,571
Total Stockholders’ Equity		71,884			97,320			56			(97,376	)		71,884
Total Liabilities and Stockholders’ Equity	$	178,709		$	239,325		$	1,980		$	(180,559	)	$	239,455
Condensed Consolidating Statement of Operations -				Guarantor			Non-Guarantor
Three Months Ended December 31, 2006	Parent			Subsidiaries			Subsidiary			Eliminations			Consolidated
Revenues	$	—		$	34,565		$	344		$	(21	)	$	34,888
Cost of Revenues		—			21,698			303			(21	)		21,980
Gross Profit		—			12,867			41			—			12,908
Operating Expenses		—			8,388			125			—			8,513
Operating Income (Loss)		—			4,479			(84	)		—			4,395
Interest and Other Income		3,255			93			1			(3,255	)		94
Interest Expense		3,255			3,303			—			(3,255	)		3,303
Income (Loss) from Continuing Operations before Income Tax and Equity Account for Subsidiaries		—			1,269			(83	)		—			1,186
Income Tax Expense		—			547			—			—			547
Income (Loss) from Continuing Operations before Equity Account for Subsidiaries		—			722			(83	)		—			639
Equity Account for Subsidiaries		639			—			—			(639	)		—
Net Income (Loss) from Continuing Operations	$	639		$	722		$	(83	)	$	(639	)	$	639
Condensed Consolidating Statement of Operations -				Guarantor			Non-Guarantor
Three Months Ended December 31, 2005	Parent			Subsidiaries			Subsidiary			Eliminations			Consolidated
Revenues	$	—		$	16,107		$	378		$	—		$	16,485
Cost of Revenues		—			11,802			337			—			12,139
Gross Profit		—			4,305			41			—			4,346
Operating Expenses		—			5,374			91			—			5,465
Operating Loss		—			(1,069	)		(50	)		—			(1,119	)
Interest and Other Income		1,069			874			1			(1,069	)		875
Interest Expense		1,069			1,069			—			(1,069	)		1,069
Loss from Continuing Operations before Income Tax and Equity Account for Subsidiaries		—			(1,264	)		(49	)		—			(1,313	)
Income Tax Benefit		—			(523	)		—			—			(523	)
Loss from Continuing Operations before Equity Account for Subsidiaries		—			(741	)		(49	)		—			(790	)
Equity Account for Subsidiaries		(790	)		—			—			790			—
Net Loss from Continuing Operations	$	(790	)	$	(741	)	$	(49	)	$	790		$	(790	)

- 20 -

Condensed Consolidating Statement of Cash Flows -				Guarantor			Non-Guarantor
Three Months Ended December 31, 2006	Parent			Subsidiaries			Subsidiary			Eliminations		Consolidated
Net Cash Used by Operating Activities	$	—		$	(3,392	)	$	(589	)	$	—	$	(3,981	)
Cash Flows from Investing Activities:
Capital expenditures		—			(1,423	)		(7	)		—		(1,430	)
Discontinued operations, net		—			7,510			—			—		7,510
Net Cash Provided (Used) in Investing Activities		—			6,087			(7	)		—		6,080
Cash Flows from Financing Activities:
Payments of long-term debt		(7,230	)		(57	)		—			—		(7,287	)
Intercompany advances, net		7,230			(7,806	)		576			—		—
Net Cash Provided (Used) by Financing Activities		—			(7,863	)		576			—		(7,287	)
Net Change in Cash and Cash Equivalents		—			(5,168	)		(20	)		—		(5,188	)
Cash and Cash Equivalents, Beginning of Period		—			6,758			114			—		6,872
Cash and Cash Equivalents, End of Period	$	—		$	1,590		$	94		$	—	$	1,684
Condensed Consolidating Statement of Cash Flows -				Guarantor			Non-Guarantor
Three Months Ended December 31, 2005	Parent			Subsidiaries			Subsidiary			Eliminations		Consolidated
Net Cash Provided (Used) by Operating Activities	$	—		$	(5,890	)	$	156		$	—	$	(5,734	)
Cash Flows from Investing Activities:
Acquisition of businesses		—			(111,471	)		—			—		(111,471	)
Capital expenditures		—			(2,424	)		(19	)		—		(2,443	)
Proceeds from sale of assets		—			2,395			—			—		2,395
Discontinued operations, net		—			(200	)		—			—		(200	)
Net Cash Used in Investing Activities		—			(111,700	)		(19	)		—		(111,719	)
Cash Flows from Financing Activities:
Proceeds from the issuance of long-term debt		85,000			—			—			—		85,000
Payments of long-term debt		(162	)		—			—			—		(162	)
Debt issuance costs		(1,677	)		—			—			—		(1,677	)
Intercompany advances, net		(83,161	)		83,161			—			—		—
Discontinued operations, net		—			(10	)		—			—		(10	)
Net Cash Provided by Financing Activities		—			83,151			—			—		83,151
Net Change in Cash and Cash Equivalents		—			(34,439	)		137			—		(34,302	)
Cash and Cash Equivalents, Beginning of Period		—			37,079			134			—		37,213
Cash and Cash Equivalents, End of Period	$	—		$	2,640		$	271		$	—	$	2,911

- 21 -